|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
|LCTX||Lineage Cell Therapeutics||2.74||-0.09||-3.18%||442.9M|
You can purchase shares of Lineage Cell Therapeutics (AMEX: LCTX) through any online brokerage.
There are no as such competitors for Lineage Cell Therapeutics.
The latest price target for Lineage Cell Therapeutics (AMEX: LCTX) was reported by Cantor Fitzgerald on 2021-03-31. The analyst firm set a price target for 6.00 expecting LCTX to rise to within 12 months (a possible 118.98% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Lineage Cell Therapeutics (AMEX: LCTX) is $2.74 last updated Fri May 07 2021 19:59:51 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Lineage Cell Therapeutics.
There is no upcoming split for Lineage Cell Therapeutics.